Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.36 | -7.35 |
| PEG Ratio (TTM) | -0.06 | -0.01 |
| P/S Ratio (TTM) | 0.45 | 2.11 |
| P/B Ratio (TTM) | 0.92 | 1.58 |
| P/FCF Ratio (TTM) | 1.65 | 10.80 |
| Price to 5YR AVG Earnings Ratio | 1.82 | 4.71 |
| Price to 5YR AVG FCF Ratio | 1.04 | 8.71 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -20.18% | 6.25% |
| ROE (TTM) | -74.98% | 9.25% |
| Net Profit Margin (TTM) | -32.81% | 16.46% |
| ROIC 5YR AVG | 49.83% | 13.23% |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -97.35% | 1,648.09% | 956.30% |
| Revenue | 11.30% | 63.78% | 29.90% |
| Net Income | -97.76% | 1,652.20% | 959.56% |
| Cash Flow | 43.90% | 260.09% | 139.86% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.04 | 1.72 |
| Quick Ratio (TTM) | 0.97 | 1.56 |
| D/E Ratio (TTM) | 0.55 | 0.67 |
| Interest Coverage (TTM) | -3.98 | 12.88 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 0.45 | 2.15 |
| LTL to 5YR AVG FCF | 0.03 | 3.23 |
| Shares Outstanding Growth 5YR AVG | 3.03% | 10.71% |